This journal is a peer reviewed, open access journal.
All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute. Permitted reuse is defined by the following user license:Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
If you need to comply with your funding body policy you can apply for a CC BY license after your manuscript is accepted for publication.Open Access Publication Fee
As an open access journal with no subscription charges, a fee is payable by the author or research funder to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.To celebrate the launch of Elsevier's Oncology Journal Network we are pleased to offer a 20% discount on the article publishing charge for manuscripts submitted before 30 April 2020.There is an additional 30% discount off the open access publication fee for members of the European SocieTy for Radiotherapy & Oncology (ESTRO). Prices are listed below (excluding taxes).
|Full Price, excluding taxes||Discounted Price until 30 April 2020, excluding taxes|
|Original Research Articles and Review Articles||EUR 1500||EUR 1200|
|Case series articles, Case reports, Technical notes and Short communications||EUR 560||EUR 448|
* To be eligible for the society member discount the corresponding author must be a member of the European SocieTy for Radiotherapy & Oncology (ESTRO). To claim the discount the author can verify their membership at article submission stage. Elsevier reserves the right to remove or refuse the discount.
Research4Life Article Publishing Charge waiver and discount options
We automatically apply Article Publishing Charge waivers or discounts to those articles in gold open access journals for which all authors are based in a country eligible for the Research4Life program.
Find out more about the APC waiver and discount eligibility.
Elsevier has established agreements with funding bodies, including Wellcome Trust and Research Councils UK. This ensures authors can comply with funding body open access policies and may also be reimbursed for their publication fees.Author Rights
For open access publishing this journal uses an exclusive licensing agreement. Authors will retain copyright alongside scholarly usage rights and Elsevier will be granted publishing and distribution rights.Publishing Schedule
This journal publishes 12 issues a year.
Learn More about: